PureTech Health (PRTC) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free PRTC Stock Alerts $28.68 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 27, 2024 | seekingalpha.comPureTech Health plc (PRTC) Q4 2023 Earnings Call TranscriptApril 25, 2024 | finance.yahoo.comPureTech Announces Annual Results for Year Ended December 31, 2023April 18, 2024 | businesswire.comPureTech Health: Notice of ResultsApril 17, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $25.48PureTech Health (NASDAQ:PRTC) Shares Gap Up to $25.48April 16, 2024 | finance.yahoo.comPureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisApril 11, 2024 | lse.co.ukUS FDA hands fast track to PureTech head and neck cancer treatmentApril 11, 2024 | markets.businessinsider.comPureTech's LYT-200 Receives FDA Fast Track Designation For Treatment Of Head & Neck CancersApril 11, 2024 | businesswire.comPureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersApril 10, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading VolumePureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading VolumeApril 9, 2024 | businesswire.comPureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsApril 5, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Trading Down 5.9%PureTech Health (NASDAQ:PRTC) Stock Price Down 5.9%April 4, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Sets New 52-Week High at $34.00PureTech Health (NASDAQ:PRTC) Hits New 1-Year High at $34.00April 2, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $30.00PureTech Health (NASDAQ:PRTC) Shares Gap Down to $30.00April 1, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $28.50PureTech Health (NASDAQ:PRTC) Shares Gap Up to $28.50March 27, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $29.40PureTech Health (NASDAQ:PRTC) Shares Gap Down to $29.40March 18, 2024 | businesswire.comBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionMarch 13, 2024 | finance.yahoo.comPureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 3.000 callFebruary 27, 2024 | lse.co.ukPureTech notes positive results from Shionogi's EndeavorRx ADHD trialFebruary 27, 2024 | finance.yahoo.comPureTech to Present at Two Upcoming Investor ConferencesFebruary 27, 2024 | businesswire.comPureTech to Present at Two Upcoming Investor ConferencesFebruary 27, 2024 | finance.yahoo.comPureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 27, 2024 | businesswire.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 23, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Sees Strong Trading VolumePureTech Health (NASDAQ:PRTC) Sees Large Volume IncreaseFebruary 22, 2024 | finance.yahoo.comPureTech Health plc (PRTC)February 21, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $26.12PureTech Health (NASDAQ:PRTC) Shares Gap Down to $26.12February 20, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Trading Up 4%PureTech Health (NASDAQ:PRTC) Shares Up 4%February 15, 2024 | finance.yahoo.comDown -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a TurnaroundFebruary 9, 2024 | fool.co.ukLSE:PRTC (PureTech Health plc)February 7, 2024 | marketbeat.comLeerink Partnrs Equities Analysts Boost Earnings Estimates for PureTech Health plc (NASDAQ:PRTC)PureTech Health plc (NASDAQ:PRTC - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2023 earnings per share (EPS) estimates for shares of PureTech Health in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith now expects that the company will post earniFebruary 6, 2024 | marketbeat.comAnalysts Issue Forecasts for PureTech Health plc's FY2028 Earnings (NASDAQ:PRTC)PureTech Health plc (NASDAQ:PRTC - Free Report) - Research analysts at Leerink Partnrs issued their FY2028 earnings per share (EPS) estimates for PureTech Health in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per shareJanuary 30, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $26.60PureTech Health (NASDAQ:PRTC) Shares Gap Down to $26.60January 29, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $25.63PureTech Health (NASDAQ:PRTC) Shares Gap Up to $25.63January 23, 2024 | seekingalpha.comPRTC PureTech Health plcJanuary 11, 2024 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Short Interest UpdatePureTech Health plc (NASDAQ:PRTC - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 500 shares, an increase of 400.0% from the December 15th total of 100 shares. Based on an average daily trading volume, of 3,400 shares, the days-to-cover ratio is currently 0.1 days.December 20, 2023 | msn.comPureTech outlook for 2024December 7, 2023 | finance.yahoo.comPureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023November 14, 2023 | msn.comPureTech Phase 2 study for anti-anxiety drug LYT-300 meets primary endpointOctober 11, 2023 | finance.yahoo.comPureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual MeetingOctober 6, 2023 | bizjournals.comAt Women Who Lead in Life Sciences, female leaders got the spotlight [PHOTOS]October 5, 2023 | bizjournals.comThe Petri Dish: Flagship startup hires GSK leader; Biogen cuts digital health groupOctober 4, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track DesignationSeptember 28, 2023 | finance.yahoo.comKarXT, invented at PureTech, submitted for FDA Approval in SchizophreniaSeptember 27, 2023 | finance.yahoo.comPureTech Announces the Appointment of Robert Lyne as Chief Portfolio OfficerSeptember 1, 2023 | marketbeat.comFY2023 Earnings Forecast for PureTech Health plc (NASDAQ:PRTC) Issued By Leerink PartnrsPureTech Health plc (NASDAQ:PRTC - Free Report) - Research analysts at Leerink Partnrs cut their FY2023 EPS estimates for PureTech Health in a note issued to investors on Tuesday, August 29th. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($4.45) per share for the yeAugust 29, 2023 | msn.comHere’s why this could be one of the best UK growth stocks to buy right nowAugust 11, 2023 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Sees Large Increase in Short InterestPureTech Health plc (NASDAQ:PRTC - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 1,600 shares, an increase of 1,500.0% from the July 15th total of 100 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is currently 4.0 days.June 30, 2023 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Short Interest Down 50.0% in JunePureTech Health plc (NASDAQ:PRTC - Free Report) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the May 31st total of 200 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is currently 0.2 days.May 11, 2023 | technews.tmcnet.comPURETECH DELIVERS NUMEROUS INNOVATIONS TO INCREASE ROI OF ITS LEADING WIDE AREA VIDEO SURVEILLANCE SOLUTION INCLUDING FALSE ALARM ELIMINATIONMay 11, 2023 | msn.comPureTech Health (LSE:PRTC) Price Target Decreased by 6.32% to 605.20 Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address A once-in-a-century investment opportunity (Ad)It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead. To get its name and ticker symbol for free - just click here. PRTC Media Mentions By Week PRTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼1.870.50▲Average Medical News Sentiment PRTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼01▲PRTC Articles Average Week Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AUPH News PAHC News NRIX News SAGE News NUVB News WVE News PRAX News COGT News IRON News ALXO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
